Medication Adherence and Incident Preventable Hospitalizations for Hypertension

American Journal of Preventive Medicine

Volumn 50, Issue 4, 2016, Pages 489-499

  Will, Julie C ^a   Zhang, Zefeng ^a   Ritchey, Matthew D ^a   Loustalot, Fleetwood ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ALGORITHM; AMBULATORY CARE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DATA BASE; EMPLOYEE; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT COMPLIANCE; PROPHYLAXIS; RISK FACTOR; YOUNG ADULT; ADOLESCENT; FACTUAL DATABASE; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84961127095     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2015.08.021     Document Type: Article

References (41)

1. J. Billings, L. Zeitel, J. Lukomnik, T.S. Carey, A.E. Blank, and L. Newman Impact of socioeconomic status on hospital use in New York City Health Aff (Millwood) 12 1 1993 162 173 10.1377/hlthaff.12.1.162
2. J.S. Weissman, C. Gatsonis, and A.M. Epstein Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland JAMA 268 17 1992 2388 2394 10.1001/jama.1992.03490170060026
3. E. Moy, E. Chang, and M. Barrett Potentially preventable hospitalizations - United States, 2001-2009 MMWR Surveill Summ 62 suppl 3 2013 139 143
4. J.C. Will, and P.W. Yoon Preventable hospitalizations for hypertension: establishing a baseline for monitoring racial differences in rates Prev Chronic Dis 10 2013 120165 10.5888/pcd10.120165
5. J.N. Laditka, and S.B. Laditka Race, ethnicity and hospitalization for six chronic ambulatory care sensitive conditions in the USA Ethn Health 11 3 2006 247 263 10.1080/13557850600565640
6. S.K. Davis, Y. Liu, and G.H. Gibbons Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks Am J Public Health 93 3 2003 447 455 10.2105/AJPH.93.3.447
7. Russo CA, Andrews RM, Coffey RM. Racial and ethnic disparities in potentially preventable hospitalizations, 2003: Statistical brief #10. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research; 2006.
8. J.C. Will, I.A. Nwaise, L. Schieb, and Y. Zhong Geographic and racial patterns of preventable hospitalizations for hypertension: Medicare beneficiaries, 2004-2009 Public Health Rep 129 1 2014 8 18
9. S.S. O'Neil, T. Lake, A. Merrill, A. Wilson, D.A. Mann, and L.M. Bartnyska Racial disparities in hospitalizations for ambulatory care-sensitive conditions Am J Prev Med 38 4 2010 381 388 10.1016/j.amepre.2009.12.026
10. F.Z. Kettani, A. Dragomir, R. Cote, and et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention Stroke 40 1 2009 213 220 10.1161/STROKEAHA.108.522193
11. M. Krousel-Wood, E. Holt, C. Joyce, and et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO) J Hypertens 33 2 2014 412 420 10.1097/HJH.0000000000000382
12. G. Mazzaglia, E. Ambrosioni, M. Alacqua, and et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients Circulation 120 16 2009 1598 1605 10.1161/CIRCULATIONAHA.108.830299
13. S. Perreault, A. Dragomir, M. White, L. Lalonde, L. Blais, and A. Berard Better adherence to antihypertensive agents and risk reduction of chronic heart failure J Intern Med 266 2 2009 207 218 10.1111/j.1365-2796.2009.02084.x
14. S. Perreault, A. Dragomir, L. Roy, and et al. Adherence level of antihypertensive agents in coronary artery disease Br J Clin Pharmacol 69 1 2010 74 84 10.1111/j.1365-2125.2009.03547.x
15. J.E. Bailey, J.Y. Wan, J. Tang, M.A. Ghani, and W.C. Cushman Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death J Gen Intern Med 25 6 2010 495 503 10.1007/s11606-009-1240-1
16. A. Dragomir, R. Cote, L. Roy, and et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs Med Care 48 5 2010 418 425 10.1097/MLR.0b013e3181d567bd
17. M.C. Sokol, K.A. McGuigan, R.R. Verbrugge, and R.S. Epstein Impact of medication adherence on hospitalization risk and healthcare cost Med Care 43 6 2005 521 530 10.1097/01.mlr.0000163641.86870.af
18. G. Corrao, A. Parodi, F. Nicotra, and et al. Better compliance to antihypertensive medications reduces cardiovascular risk J Hypertens 29 3 2011 610 618 10.1097/HJH.0b013e328342ca97
19. L.D. Esposti, S. Saragoni, S. Benemei, and et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients Clinicoecon Outcomes Res 3 2011 47 54 10.2147/CEOR.S15619
20. Danielson E. White paper: Health research data for the real world: the MarketScan Databases. http://truvenhealth.com/Portals/0/Users/031/31/31/PH-13434%200314-MarketScan-WP-web.pdf. Published January 2014. Accessed March 18, 2015.
21. Chronic Conditions Warehouse. Centers for Medicare and Medicaid Services. www.ccwdata.org/web/guest/condition-categories. Accessed March 18, 2015.
22. Medication Management Measures. The National Quality Forum. www.qualityforum.org/Publications/2010/05/National-Voluntary-Consensus-Standards-for-Medication-Management.aspx. Accessed March 18, 2015.
23. D. Nau Proportion of days covered (PDC) as a preferred measure of medication adherence Pharmacy Quality Alliance 2015 Accessed March 18, 2015 www.pqaalliance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf
24. N.K. Choudhry, W.H. Shrank, R.L. Levin, and et al. Measuring concurrent adherence to multiple related medications Am J Manag Care 15 7 2009 457 464
25. HRSA USDHHS Bureau of Health Professions Area Health Resources Files (AHRF) 2015 Accessed March 18, 2015 http://ahrf.hrsa.gov/
26. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 1987 373 383 10.1016/0021-9681(87)90171-8
27. J. Tang, J.Y. Wan, and J.E. Bailey Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population Stroke 39 7 2008 1938 1944 10.1161/STROKEAHA.107.504688
28. Agency for Health Care Research and Quality. Prevention quality indicators technical specifications. www.qualityindicators.ahrq.gov/modules/pqi-resources.aspx. Accessed March 18, 2015.
29. S.H. Simpson, D.T. Eurich, S.R. Majumdar, and et al. A meta-analysis of the association between adherence to drug therapy and mortality BMJ 333 7557 2006 15 10.1136/bmj.38875.675486.55
30. Bureau of Economic Analysis. Domestic product and income, Table 1.1.4. www.bea.gov/iTable/iTable.cfm?ReqID=9&step=1#reqid=9&step=3&isuri=1&903=4. Accessed March 18, 2015.
31. D.R. Cox Regression models and life-tables J R Stat Soc Series B 34 2 1972 187 220
32. J. Nelder, and R. Wedderburn Generalized linear models J R Stat Soc Series A 135 3 1972 370 384 10.2307/2344614
33. M.A. Krousel-Wood, P. Muntner, T. Islam, D.E. Morisky, and L.S. Webber Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults Med Clin North Am 93 3 2009 753 769 10.1016/j.mcna.2009.02.007
34. M.R. Nelson, C.M. Reid, P. Ryan, K. Willson, and L. Yelland Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2) Med J Aust 185 9 2006 487 489
35. N.S. Breekveldt-Postma, F.J. Penning-van Beest, S.J. Siiskonen, and et al. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke Curr Med Res Opin 24 1 2008 121 127 10.1185/030079908X253843
36. P.M. Ho, D.J. Magid, S.M. Shetterly, and et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease Am Heart J 155 4 2008 772 779 10.1016/j.ahj.2007.12.011
37. Viswanathan MGC, Jones CD, Ashok M, et al. Medication Adherence Interventions: Comparative Effectiveness. Closing the Quality Gap: Revisiting the State of the Science. Evidence Report No. 208. (Prepared by RTI International-University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I.) AHRQ Publication No. 12-E010-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed March 18, 2015.
38. G. Ogedegbe, W. Chaplin, A. Schoenthaler, and et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans Am J Hypertens 21 10 2008 1137 1143 10.1038/ajh.2008.240
39. M.S. Beckowski, A. Goyal, R.Z. Goetzel, C.L. Rinehart, K.J. Darling, and C.M. Yarborough Developing alternative methods for determining the incidence, prevalence, and cost burden of coronary heart disease in a corporate population J Occup Environ Med 54 8 2012 1026 1038 10.1097/JOM.0b013e318256f636
40. C. Hsu, J.M. Lemon, E.S. Wong, and et al. Factors affecting medication adherence: patient perspectives from five veterans affairs facilities BMC Health Serv Res 14 1 2014 533 10.1186/s12913-014-0533-1
41. R. Iyengar, R. Henderson, J. Visaria, and S. Glave Frazee Dispensing channel and medication adherence: evidence across 3 therapy classes Am J Manag Care 19 10 2013 798 804